Eli Lilly's (LLY) sees a 60% sales jump from April to May in India for its obesity/ diabetes drug Mounjaro. Read more here.

The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...

CompanyOverview|NYSE:NVO] Despite a massively successful run as Chief Executive Officer (CEO) of pharma giant Novo Nordisk ...

The manufacturer of Mounjaro has responded to dangerous hack that’s been doing the rounds on social media. Videos of people ...

SINGAPORE—China is racing toward economic self-sufficiency by weaning itself off American technology. But it has made a ...

Helgi Kormaksson Joins CTS Executive Team SAN FRANCISCO, CA / ACCESS Newswire / June 6, 2025 / CTS is excited to announce that Helgi Kormaksson has joined the company as Chief Design Officer. Helgi ...

Diabetes care startup Omada Health went public Friday 14 years after its founding. Here's what its major investors' stakes ...

US drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could be ...

With three months since its launch in India, according to latest Pharmatrac data, Mounjaro clocked Rs 12.6 crore in sales in May 2025—a threefold increase from March ...

Health-care companies rose as investors bet on anti-obesity products. Omada Health shares jumped after the maker of digital products that help track diet and other diabetes factors made its ...

Purdue University's 50-year plan for Indianapolis campus development includes 16 new buildings including the 15-floor ...

Yahoo Finance senior health reporter Anjalee Khemlani explains the pharmaceutical industry's push into domestic manufacturing ...